Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Yale University
mi
from
New Haven, CT
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Mental Health Advocates
mi
from
Boca Raton, FL
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Mental Health Advocates
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Miami School of Medicine
mi
from
Miami, FL
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Emory University
mi
from
Atlanta, GA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Medical College of Georgia
mi
from
Augusta, GA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Iowa
mi
from
Iowa City, IA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Clinical Research Institute
mi
from
Wichita, KA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Clinical Research Institute
mi
from
Wichita, KA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Lousiana State University Health Sciences Center
mi
from
Shreveport, LA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Lousiana State University Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Clinical Insights Inc
mi
from
Glen Burnie, MD
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Clinical Insights Inc
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Freedom Trail Clinic
mi
from
Boston, MA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Freedom Trail Clinic
mi
from
Boston, MA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
John C Corrigan Community Mental Health Center
mi
from
Fall River, MA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
John C Corrigan Community Mental Health Center
mi
from
Fall River, MA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Massachusetts
mi
from
Worcester, MA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Wayne State University
mi
from
Detroit, MI
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
New Mexico VA Healthcare System
mi
from
Albuquerque, NM
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
New Mexico VA Healthcare System
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Rochester
mi
from
Rochester, NY
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
John Umstead Hospital/Duke University
mi
from
Butner, NC
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
John Umstead Hospital/Duke University
mi
from
Butner, NC
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Carolinas HealthCare System
mi
from
Charlotte, NC
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Carolinas HealthCare System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Philadelphia VA Medical Center-116A
mi
from
Philadelphia, PA
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Philadelphia VA Medical Center-116A
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
Baylor College of Medicine
mi
from
Houston, TX
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/7/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Clinical Management of Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/7/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy
The Impact of Electroencephalographic (EEG) Seizure Treatment in Near Term ≥ 36 Weeks Gestation and Term Infants With Neonatal Encephalopathy
Status: Enrolling
Updated:  12/8/2015
St. Louis Children's Hospital
mi
from
St. Louis, MO
The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy
The Impact of Electroencephalographic (EEG) Seizure Treatment in Near Term ≥ 36 Weeks Gestation and Term Infants With Neonatal Encephalopathy
Status: Enrolling
Updated: 12/8/2015
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Interventions for Children With Attention and Reading Disorders
Reading ICARD: Interventions for Children With Attention and Reading Disorders
Status: Enrolling
Updated:  12/8/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Interventions for Children With Attention and Reading Disorders
Reading ICARD: Interventions for Children With Attention and Reading Disorders
Status: Enrolling
Updated: 12/8/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Interventions for Children With Attention and Reading Disorders
Reading ICARD: Interventions for Children With Attention and Reading Disorders
Status: Enrolling
Updated:  12/8/2015
University of Texas Health Science Center
mi
from
Houston, TX
Interventions for Children With Attention and Reading Disorders
Reading ICARD: Interventions for Children With Attention and Reading Disorders
Status: Enrolling
Updated: 12/8/2015
University of Texas Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth
RCT of an Animal-Assisted Intervention With Adjudicated Youth
Status: Enrolling
Updated:  12/8/2015
Macomb County Juvenile Justice Center
mi
from
Mt. Clemens, MI
Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth
RCT of an Animal-Assisted Intervention With Adjudicated Youth
Status: Enrolling
Updated: 12/8/2015
Macomb County Juvenile Justice Center
mi
from
Mt. Clemens, MI
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site
mi
from
Birmingham, AL
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site
mi
from
Birmingham, AL
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site
mi
from
Little Rock, AR
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 10140
mi
from
Orange, CA
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 10140
mi
from
Orange, CA
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site
mi
from
San Diego, CA
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 4
mi
from
Stanford, CA
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 4
mi
from
Stanford, CA
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 13
mi
from
Clearwater, FL
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 13
mi
from
Clearwater, FL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 10247
mi
from
Miami Lakes, FL
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 10247
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 5
mi
from
Spring Hill, FL
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 5
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 025
mi
from
Winter Park, FL
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 025
mi
from
Winter Park, FL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 096
mi
from
Atlanta, GA
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 096
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 096
mi
from
Atlanta, GA
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 096
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site
mi
from
Louisville, KY
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 015
mi
from
Grand Blanc, MI
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 015
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 3
mi
from
West Seneca, NY
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 3
mi
from
West Seneca, NY
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site
mi
from
Raleigh, NC
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 013
mi
from
Toledo, OH
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 013
mi
from
Toledo, OH
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site
mi
from
Oklahoma City, OK
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site MARK
mi
from
West Chester, PA
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site MARK
mi
from
West Chester, PA
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site
mi
from
Houston, TX
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials